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This study was conducted to explore the potential of adjuvant for the production of immunoglobulin Y (IgY) as antistreptococcosis in layer 
chicken with mass production orientation. Enterococcus faecalis which causes streptococcosis in the red tilapia was selected as a candidate 
antigen. The production of immunoglobulin Y (IgY) was carried out on Isa Brown layer chickens and aged around 20 weeks. Furthermore, the 
chickens were grouped into four groups (A, B, C, and D groups), each consisting of three chickens based on the type of adjuvant, while two 
chickens were used as a control group. Each group was treated by giving MONTANIDE™ ISA 71R VG adjuvant (A),  Freund's adjuvant (B), 
aluminum potassium sulphate adjuvant (KAl(SO4)2∙12H2O) concentration of 50 ppm in pH 7 (C), and  only antigens without adjuvant (D).  
Chickens were kept for 35 days and each week was checked for presence the IgY antigen in the serum and egg yolk. Booster was conducted on 
14th and 28th days of maintenance. The results showed that IgY in treatment group A was detected on day 28 in the serum and day 35 in the yolk. 
Whereas the treatment group B could be detected on day 35 in the serum. However, the IgY was not detected in the serum and yolk in C, D, and 
control groups until the end of the maintenance. Based on the results, it can be concluded that the appearance of IgY in serum and yolk in a 
relatively fast time is obtained in the combination of Enterococcus faecalis antigen with the emulsion of water-in-oil adjuvant (SEPPIC 
MONTANIDE™ ISA 71R VG) compared to the other types of adjuvant that use in this study. 
____________________________________________________________________________________________________________________ 




Penelitian ini bertujuan mengeksplorasi potensi adjuvan dalam produksi imunoglobulin Y (IgY) sebagai antistreptococcosis pada ayam 
petelur layer dengan orientasi produksi massal. Enterococcus faecalis sebagai penyebab penyakit streptococcosis pada nila merah dipilih 
sebagai kandidat antigen. Uji produksi IgY dilakukan pada ayam petelur Isa Brown yang berumur sekitar 20 minggu lalu dibagi menjadi empat 
kelompok perlakuan (A, B. C, dan D). Setiap kelompok perlakuan terdiri atas tiga ekor ayam, sedangkan untuk kelompok kontrol terdiri atas dua 
ekor ayam. Perlakuan yang diberikan adalah pemberian adjuvan MONTANIDE ™ ISA 71R VG (A), adjuvan Freund (B), adjuvan aluminium 
kalium sulfat (KAl(SO4)2∙12H2O) konsentrasi 50 ppm dalam pH 7 (C), dan antigen tanpa adjuvan (D). Ayam-ayam tersebut dipelihara selama 35 
hari, dan setiap minggu dilakukan pemeriksaan terhadap keberadaan IgY dalam serum dan kuning telur. Vaksinasi ulang dilakukan pada hari 
ke-14 dan ke-28 hari pemeliharaan. Hasil penelitian menunjukkan bahwa IgY pada kelompok perlakuan A mulai terdeteksi pada hari ke-28 di 
serum dan hari ke-35 di kuning telur sedangkan pada kelompok perlakuan B, IgY terdeteksi dalam serum pada hari ke-35. Tidak ada kehadiran 
IgY yang terdeteksi dalam serum dan kuning telur untuk kelompok perlakuan C, D, dan kontrol hingga akhir periode pemeliharaan. Disimpulkan 
bahwa kehadiran IgY dalam serum dan kuning telur dalam waktu yang relatif lebih cepat diperoleh dari kombinasi antigen Enterococcus 
faecalis dengan adjuvan emulsi air-dalam-minyak (SEPPIC MONTANIDE ™ ISA 71R VG) dibandingkan dengan jenis adjuvan lain yang 
digunakan dalam penelitian ini. 
____________________________________________________________________________________________________________________ 





Adjuvant is a substance that mixed with antigens 
which is more able to increase the antibody titer due to 
an increase in the immune system response compared 
to a single antigen application (Awate et al., 2013). 
One of the most ingredients that widely used as an 
adjuvant is an emulsion material, such as water-in-oil 
or W/O emulsion and a water-in-oil-in-water or 
W/O/W emulsion. In addition, mineral salts such as 
aluminum potassium sulfate, aluminum phosphate, and 
aluminum hydroxide; microorganism products such as 
Complete Freund's Adjuvant (CFA) containing dried 
preparations of inactive bacteria Mycobacterium sp.; 
saponin; type of cytokine; polymer; microparticles; and 
liposomes can also be used as adjuvants (Guy, 2007). 
In terms of safety, aluminum mineral adjuvants 
have the best safety history of their use for 70 years 
(HogenEsch, 2013). Therefore, this type of adjuvant is 
widely used in studies of immunomodulatory 
substances. The workings of mineral salt adjuvants 
such as aluminum adjuvants are largely determined by 
the optimization of the absorption of antigens by the 
aluminum mineral surfaces used as adjuvants. 
According to Hem and HogenEsch (2007), absorption 
of antigens with aluminum adjuvants is influenced by 
hydrophobicity, van der Waals forces, electrostatic 
mechanisms between antigens and adjuvants, and the 
presence of ligand changes. Therefore, the 
effectiveness of aluminum adjuvant is largely 
determined by the chemical and physical stability of the 
antigen used (HogenEsch, 2013). 
The mechanism of emulsion-type adjuvants in 
increasing antibody titers begins with the formation of 
antigen depots at the injection site in muscle tissue. The 
depot will release antigens slowly into the tissue. The 
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presence of antigen depots can also trigger the secretion 
of cytokines and chemokines that invite immune cells 
that play a role in non-specific immune systems, such 
as macrophages and other cells that are phagocytosis. 
Adjuvants also play a role in increasing antigen 
phagocytosis and macrophage activity which acts as 
antigen presenting cells (APCs). In addition, adjuvants 
also enable the activation and maturation of APCs, the 
increase of Major Histocompatibility Complex (MHC) 
class II, increased migration of the matured and 
activated APCs into lymph node flow, and ultimately 
increased activation of antibody-producing B cells in 
the process of humoral immune systems and cells 
cytotoxic T lymphocytes (CD8 + cells) in the process 
of the cellular immune system. Thus, it can be said that 
adjuvants are also an immunomodulatory material to 
improve the performance of the non-specific and 
specific immune system (Awate et al., 2013). 
The Freund adjuvant works by three mechanisms, 
namely prolonging the presence of antigens in the 
injection area, facilitating antigens to be quickly 
distributed to the lymphatic system and the lungs as the 
place where adjuvants trigger the accumulation of cells 
that work in the immune system, and allowing the third 
mechanism that has not yet been identified but suspected 
to be related to how antibodies form and how 
sensitization develops (Dienes, 1929). Complete 
Freund's adjuvant containing Mycobacterium 
tuberculosis can induce the production of some 
chemokines, tumor necroting factor α (TNF α), 
interleukin (IL) 12, IL-6, and interferon γ (IFN γ). The 
Mycobacterium sp. component will be phagocytosed by 
the dendritic cells and macrophages which are the target 
of these cells and directly cause stress that allows natural 
killer (NK) cells to secrete IFN-γ as cytokines that will 
be captured by the dendritic cells and macrophages as 
chemical signals in the phagocytic process. The dendritic 
cells and macrophages will then secrete IL-12 which can 
activate the helper T cells and humoral immune systems 
as in the mechanism of action of emulsion adjuvants 
(Billiau and Matthys, 2001). 
Shah et al. (2019) states that the droplet size of an 
adjuvant emulsion material can also affect its 
immunomodulatory potential due to differences in 
activation and direction of immune cells that lead to 
antigenic depots. The smaller emulsion droplet size (20 
nm) is less effective compared to the larger droplet size 
(~ 160 nm). Adjuvants with a 160 nm droplet allow 
better movement of immune cells to the depot where 
the antigen is injected, more antigen uptake by 
phagocytic cells, and faster APC translocation into 
lymph nodes, thereby increasing humoral and cellular 
immune responses. 
Today chicken eggs are widely used in research as a 
biological factory that produces immunoglobulin Y 
(IgY) which is specific to infectious diseases in 
aquaculture commodities. Koi Herpes Virus (KHV) in 
carp and koi (Pasaribu et al., 2012), White Spot 
Syndrome Virus (WSSV) that causes white spot 
disease in shrimp (Soejoedono, 2012), Aeromonas 
hydrophila bacterial infection in chef carp (Carassius 
auratus Gibelio) (Xiao-liang et al., 2006), and vibriosis 
in vanamei shrimp (Litopenaeus vannamei) (Gao et al., 
2016) are several diseases that have been studied in the 
development of IgY as a therapeutic basis. This was 
done as a new therapeutic effort that is more 
environmentally friendly in fighting infectious diseases 
by reducing the use of antibiotics in aquaculture 
activities. The purpose of this study was to explore the 
potency of various adjuvants for the production of 
antistreptococcal IgY using field isolates as a prospect 
for mass pellet production for the treatment of 
streptococcosis in fish. 
 
MATERIALS AND METHODS 
 
Preparation of Inactive Antigen from Enterococcus 
faecalis Field Isolate  
The Enterococcous faecalis field isolate strain 
7INB derived from the liver of red tilapia (accession 
number GenBank MT105346) which has been 
confirmed morphologically, biochemically, and 
molecularly was used as an antigen candidate in the 
production of antistreptococcal IgY. The isolate was 
inoculated on BHI broth medium with a volume of 300 
mL which was then incubated at 35 C for 24 hours. 
The media was centrifuged for 10 minutes (10000 rpm) 
and the pellets were collected. The obtained pellets 
were then washed three times with the addition of 10 
mL sterile physiological sodium chloride (NaCl) and 
then re-centrifuged for 10 minutes (10000 rpm) before 
being collected again. The pellets were then suspended 
using physiologically sterile NaCl and compared with 
McFarland 4 standard tubes to obtain an estimate of the 
desired bacterial cell concentration (10
9
 CFU/mL). The 
inactive bacteria were then confirmed by being 
regrown on the agar medium made of 5% sheep blood. 
If it did not grow, then the bacterial suspension could 
be injected as an antigen in the production of IgY in 
experimental chickens (Modified from Wibawan et al., 
2010). 
 
Production Antistreptococcosis Immunoglobulin Y 
(IgY) in Chicken 
The production of IgY was carried out on Isa 
Brown layer chicken aged around 20 weeks for 35 days 
of maintenance. The chickens were grouped into four 
groups (A, B, C, and D groups) where each group 
consisting of three chickens based on the type of 
adjuvant, while two chickens were used as a control 
group. The treatment that given in each group as 
follows: group A was treated using inactive bacterial 
antigens injection with the addition of water-in-oil 
emulsion adjuvants (MONTANIDE ™ ISA 71R VG) 
with the formulation of 60% adjuvant: 40% antigens 
(w/w); group B was injected with inactive bacterial 
antigens with the addition of CFA at the beginning of 
vaccination and Incomplete Freund's Adjuvant (IFA) at 
the first and second revaccinations, each with the 
formulation of 50% adjuvant: 50% antigen (v/v); group 
C was treated by inactive bacterial antigens injection 
with the addition of an adjuvant solution of aluminum 
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potassium sulfate (KAl (SO4)2∙12H2O) with a 
concentration of 50 ppm at pH 7; and  group D was 
injected with inactive bacterial antigens without 
adjuvants; whereas the control was a group of chickens 
that were not injected with inactive bacterial antigens. 
The treatment groups (A, B, C, and D) were 
vaccinated intramuscularly with inactivated bacterial 
antigens with a total volume of mixture (antigen and 
adjuvant) of 1 mL/chicken on the chest muscles. 




 days of the 
maintenance period, each with a total volume of 
mixture (antigen and adjuvant) of 1 mL/chicken. Serum 
and egg yolk were collected and the antibody titers 
were calculated using the Agar Gel Precipitation Test 
(AGPT) method with dilution on 0, 7, 14, 21, 28, and 
35 days after vaccination (Modified from Wibawan et 
al. 2010). During production, feed and drinking water 
were given ad libitum. The method of using 
experimental animals had been approved by the Animal 
Ethics Commission of the Institute for Research and 
Community Service of the Bogor Agricultural Institute 
(LPPM IPB) with ethical approval number: 171-2019 
IPB. 
 
Preparation of Dissolved Antigen 
Pure bacterial isolates that had been through a series 
of bacteriological examinations were inoculated on a 
150 mL BHI broth medium and then incubated at 28 C 
for 24 hours. The media was centrifuged for 10 minutes 
(10000 rpm) and the pellets were collected. The pellets 
were then washed three times with a sterile 0.9% NaCl 
solution. The pellets obtained were then given 350 µL 
of 0.2 N HCl solution and homogenized with vortex. 
The suspension was evaporated for ± 2 hours at 60 C. 
The suspension that had been evaporated was then 
given 1-3 drops of phenol red and a few drops of 1N 
NaOH solution until it turned pink so that the pH 
remained 7. The suspension that had changed in color 
was centrifuged again for 10 minutes (10000 rpm). The 
pellets were removed and the supernatant was 
collected. The supernatant was collected as dissolved 
antigen in the test using the AGPT method with 
dilution (Arnafia et al., 2016). 
 
Preparation of The Egg Yolk Extract 
Preparation of egg yolk extract was referred to 
Wibawan et al. (2018). The procedure was divided into 
two stages, namely the preparation of egg yolk Water 
Soluble Fraction (WSF) and the IgY precipitation. The 
preparation of the egg yolk began with carefully 
breaking the egg and separating the egg whites and 
yolk using filter paper. The vitelin membrane was torn 
with a tweezers until the egg yolk came out. The 
volume of the yolk was measured and then mixed with 
distillate water with pH 5.0 with the addition of 0.5 M 
HCl seven times the volume of yolk obtained. The 
mixture was frozen at -20 C and thawed at 4 C. The 
egg yolk aggregate granules were precipitated by 
centrifugation at 13500 g for 15 minutes at 4 C, and 
the supernatant was collected and filtered with filter 
paper to obtain clear WSF filtrate. The IgY 
precipitation step was carried out using solid NaCl 
which was then added to WSF up to 8.8% of the total 
WSF volume. The mixture was stirred with magnetic 
stirrer for 2 hours at room temperature, and the pH of 
the solution was adjusted to the pH point 4 by adding 
0.5 M HCl. The mixture was then centrifuged at 3700 g 
for 20 minutes at   4 C. The supernatant was removed 
and pellets were dissolved in Phosphate Buffer Saline 
(PBS). 
 
Agar Gel Precipitation Test (AGPT) Method with 
Dilution 
The AGPT method with dilution to test the presence 
of IgY was carried out in the following stages: 0.502 g 
agarose gel, 1.2 g PEG6000, 0.04 g Na-azide were 
mixed into 20 mL PBS with pH 7.2 and 20 mL distilled 
water in the Erlenmeyer tube. The Erlenmeyer was 
heated in the microwave until the gel solution became 
clear. The gel solution was removed and immediately 
molded on the object glass by taking 4 mL of the gel 
solution using a scale pipette which was then poured 
slowly until the gel solution covered the entire surface of 
the object glass and bulged. The gel solution was 
allowed to stand until it hardened. It was then perforated 
with a special AGPT puncher to make a well. 
Each serum sample or egg yolk extract was diluted 
before being put into an AGPT well using a sterile PBS 
solution. A total of 100 µL of serum sample or egg 
yolk extract was put into the microplate of well 1. 
Every 50 µL PBS solution was added to the microplate 
in eell 2 to well 12. A total of 50 µL of serum sample 
or egg yolk extract from well 1 was then put into well 2 
and a stratified dilution was performed up to well 12. 
The filling of gel wells was carried out by the 
following steps. The middle well was filled with 50 μL 
of dissolved bacterial antigen, and the other wells were 
filled with 50 μL of serum sample or egg yolk extract. 
All wells were then incubated for ± 24 hours in a moist 
container covered with wet tissue at room temperature. 
Positive results were shown by the presence of whitish 
precipitation lines between wells containing dissolved 
antigens and wells containing serum samples or egg yolk 
extracts suspected of containing IgY (Oudin, 1946). 
 
RESULTS AND DISCUSSION 
 
Serum examination showed that IgY was only 
present in the treatment groups which were given 
antigens with a combination of adjuvant emulsions in 
water oil (MONTANIDE ™ ISA 71R VG) and 
antigens with a combination of Freund adjuvants. The 
IgY was formed during 35 days maintenance period. In 
two chickens in the water-oil emulsion adjuvants group 
(MONTANIDE ™ ISA 71R VG), IgY began to be 
detected in the serum on day 28 after the initial 
vaccination and the first revaccination on day 14. 
Whereas in one chicken in the Freund adjuvant group, 
IgY was only detected on day 35 after initial 
vaccination and the first and second revaccinations on 
day 14 and day 28. Negative results were found in all 
chickens in the group C which was treated with 
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aluminum potassium sulfate mineral salt adjuvant and 
the group D that were given antigens without the 
adjuvant combination. 
The IgY was detected in the yolk extract of two 
chickens from group A which were given   the antigen 
with a combination of water-in-oil emulsion adjuvant 
(MONTANIDE ™ ISA 71R VG) on day 35. The two 
individuals chicken also showed positive results on 
serum examination. Furthermore, negative results were 
observed in all egg yolk extracts from the Freund 
adjuvant group (group B), aluminum potassium sulfate 
adjuvant group (group C), and chicken groups given 
antigens without adjuvant combinations (group D). The 
results of IgY titer examination are presented in Table 
1, Table 2, Table 3, and Table 4.  
Results of studies on the potential of adjuvants as an 
immunopotentiation material in the production process 
of antistreptococcal IgY showed that the vaccine 
formulations using antigens from the field isolate 
Enterococcus faecalis with the addition of aluminum 
potassium sulfate adjuvant concentrations of 50 ppm at 
pH 7 did not cause a significant immune response until 
the end of the maintenance period. This is indicated by 
the negative AGPT test results or the absence of 
precipitation lines in all three chickens from this 
adjuvant group. According to Hem and HogenEsch 




IgY titer (2n) 
Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 
A Chicken 1 – – – – – – 
Chicken 2 – – – – 22 25 
Chicken 3 – – – – – 21 
B Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
Chicken 3 – – – – – 20 
C Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
Chicken 3 – – – – – – 
D Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
Chicken 3 – – – – – – 
Control Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
(–)= Negative (no precipitation lines), n = Dilution, A = Inactive bacteria + water-in-oil emulsion (MONTANIDE ™ ISA 71R VG) adjuvant, B = 
Inactive bacteria + Freund adjuvant, C = Inactive bacteria + adjuvant of mineral salts of potassium aluminum sulfate (KAl(SO4)2∙12H2O), and D= 
Inactive bacteria without adjuvants 
 
Table 2. Positive results for Agar Gel Precipitation Test (AGPT) method with dilution of serum 
Treatment code Chicken number 
IgY titer (2n) 


















(–)= Negative (no precipitation line), n = Dilution to, A = Inactive bacteria + water emulsion in oil (MONTANIDE ™ ISA 71R VG) adjuvant, B 
= Inactive bacteria + Freund adjuvant 
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(2007), absorption of antigens with aluminum 
adjuvants is influenced by hydrophobicity, van der 
Waals forces, electrostatic mechanisms between 
antigens and adjuvants, and the presence of ligand 
changes. Electrostatic mechanism as one of the factors 
that influence the success of vaccination using 
adjuvants containing aluminum minerals is strongly 
influenced by three things, namely the pH during the 
vaccine formulation process, point-of-zero-charge 
(PZC) of the aluminum adjuvant used, and isoelectric 
points of antigen protein used. Aluminum Adjuvants 
have different PZCs. Likewise, isoelectric points on 
proteins that become antigens. For example, the 
aluminum phosphate adjuvant has a PZC point at pH 5, 
where the adjuvant is neutral. If aluminum phosphate is 
in an environment of pH <5, the surface of the adjuvant 
will be positively charged. Meanwhile, if the aluminum 
phosphate is in an environment with a pH>5, the 
adjuvant surface will change to be negatively charged. 
An antigen in the form of an ovalbumin protein (OVA) 
has an isoelectric point at pH 4.6, where the protein is 
neutral. If OVA is in an environment with a pH <4.6, 
the protein will be positively charged. Meanwhile, if 
the OVA protein is in an environment with a pH>4.6, 
the protein will be negatively charged. Vaccine 
formulations that have a pH of 7 (neutral) will cause 
both aluminum phosphate and OVA proteins to be 
negatively charged, so they have no affinity or bonds. 
This can cause a failure in the adsorption process to 
stimulate the immune system because antigens are not 
bound by adjuvants. However, the opposite will occur 
if the OVA protein is combined with an aluminum 
hydroxide adjuvant that has a PZC point at pH 11.4. If 
the aluminum hydroxide is in an environment of pH 
<11.4, then the surface of the adjuvant will be 
positively charged. Meanwhile, if the aluminum 
hydroxide is in an environment with a pH>11.4, then 
the adjuvant surface will change to be negatively 
charged. If the vaccine formulation is maintained at pH 
7, then the surface of the aluminum hydroxide adjuvant 
will be positively charged and the OVA protein will be 
negatively charged. This will cause an electrostatic 




Titer IgY (2n) 
Day 0 Day 7 Day 14 Day 21 Day 28 Day 35 
A Chicken 1 – – – – – – 
Chicken 2 – – – – – 20 
Chicken 3 – – – – – 20 
B Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
Chicken 3 – – – – – – 
C Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
Chicken 3 – – – – – – 
D Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
Chicken 3 – – – – – – 
Control Chicken 1 – – – – – – 
Chicken 2 – – – – – – 
(–)= Negative (no precipitation lines), n = Dilution, A = Inactive bacteria + water-in-oil emulsion (MONTANIDE ™ ISA 71R VG) adjuvant, B = 
Inactive bacteria + Freund adjuvant, C = Inactive bacteria + adjuvant of mineral salts of potassium aluminum sulfate (KAl(SO4)2∙12H2O), and 
D= Inactive bacteria without adjuvants 
 
Table 4. Positive results for agar gel precipitation test (AGPT) method with dilution of egg yolk 
Treatment code Chicken number 
IgY titer (2n) 












(–)= Negative (no precipitation line), n = Dilution, A = Inactive bacteria + water-in-oil emulsion (MONTANIDE ™ ISA 71R VG) adjuvant 
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mechanism, in which the antigen will be absorbed by 
the adjuvant and cause an immunostimulatory effect 
(HogenEsch, 2013; Lindblad and Duroux, 2017). 
The negative results on the immune response of the 
formation of antistreptococcal IgY in the aluminum 
potassium sulfate adjuvant group is thought to be related 
to the fact that the electrostatic mechanism between the 
surface of the aluminum potassium sulfate adjuvant and 
the Enterococcus faecalis antigen used during the 
vaccination process did not occur optimally. The vaccine 
formulation used in this study, which was a combination 
of intact cell antigens from Enterococcus faecalis 
bacterium and aluminum potassium sulfate adjuvant at a 
concentration of 50 ppm at pH 7, is thought to have the 
same effect, namely analogy between aluminum 
phosphate antigen formulations and antigens in the form 
of proteins ovalbumin is maintained at pH 7, electrostatic 
mechanisms did not occur because they both had the 
same charge. As a result, the immune system in chicken 
was not stimulated until the end of the maintenance 
period because antigens were not bound and absorbed by 
adjuvants. However, further studies need to be carried 
out on the PZC points held by aluminum potassium 
sulfate adjuvants and the isoelectric points of each 
protein contained in Enterococcus faecalis bacterial cells 
used as antigens, so that an optimal pH environment is 
obtained during the vaccine formulation.  
The IFA adjuvants contain an essential paraffin oil 
emulsion where mannide monooleate is used as a 
surfactant. The adjuvants will form emulsions of water 
in oil (water phase) when interacting with aqueous 
solution or antigen suspension. Meanwhile, CFA 
adjuvants containing Mycobacterium tuberculosis and 
inactivated by heating work by pathogenesis of lesio 
tubercles in the injected tissue. Exposure to the 
Mycobacterium component causes an immune response 
that is delayed-type hypersensitivity (DTH) (Billiau 
and Mattys, 2001). The DTH is also called 
hypersensitivity type IV which requires time to produce 
an excessive immune response. The process of DTH 
can be divided into three phases. The first phase is the 
sensitization phase, in which the process of forming 
and exposing antigens to immunocompetent cells 
occurs the first time. The second phase is the phase of 
development, in which sensitive lymphocytes are 
produced specifically. The third phase begins after the 
administration of new antigens for the second time to 
make lymphocytes recognize the antigen more 
effectively. The process that occurs in this last phase 
will later develop into a typical inflammatory reaction. 
Furthermore, there are two models in the occurrence of 
DTH. The first is the permanent type in which the 
hypersensitivity reaction lasts for several months or 
years after the sensitization stage is complete, and the 
inflammatory reaction can still be seen up to 72-96 
hours after intradermal injection exposure. The second 
is a temporary type in which the hypersensitivity 
reaction disappears one to two weeks after the 
sensitization process, and the peak of inflammation 
occurs 24 hours after injection with lesions that will 
disappear on days 48-72 (de Weck, 1998). This DTH 
condition is thought to cause IgY titers in the Freund 
adjuvant group to take longer than the adjuvant type of 
water-in-oil emulsion (MONTANIDE ™ ISA 71R VG) 
used in this study. This condition also requires 
revaccination a second time to produce IgY titers in the 
serum so that the lymphocytes responsible for the 
immune process can further recognize the antigen 
being exposed. 
Adjuvants of water-in-mineral-oil or W/O emulsion 
type are a formulation that is very often used in 
inactivated vaccines for poultry commodities. This 
adjuvant can induce antigens in the long run because it 
contains a mixture of specific mineral oil and a 
surfactant system that can stabilize the emulsion and 
vaccine depot in the tissue (Heegaard et al., 2011). 
MONTANIDE ™ ISA 71R VG adjuvant is an example 
of a commercial type of water-in-oil emulsion that has 
been widely used in poultry vaccination programs. A 
special surfactant system that can stabilize commercial 
adjuvants for 7-30 days at 4 C, 20 C, and 37 C after 
vaccine formulation is thought to be the reason for the 
success rate in making antigen depots in the tissues 
high (Arous et al., 2013). This triggers the slow release 
of antigens and forms the immune system in gradual 
but stable and strong way, so that IgY is formed in the 




Based on the results of comparative study of the 
three types of adjuvants used in the IgY production, it 
can be concluded that the water-in-oil emulsion 
(MONTANIDE ™ ISA 71R VG) as adjuvant of can 
help increase the production of IgY in serum and egg 
yolk in a relatively faster time than without the use 
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